{
    "nctId": "NCT05955521",
    "briefTitle": "Exosome as the Prognostic and Predictive Biomarker in EBC Patients",
    "officialTitle": "Development of a Prognostic and Predictive Biomarker for Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy Using Exosome",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Triple Negative Breast Cancer, HER2-positive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Prognostic biomarker for EBC",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Early breast cancer\n* Planned neoadjuvant chemotherapy\n* Triple negative breast cancer or HER2-positive breast cancer\n\nExclusion Criteria:\n\n* Stage IV breast cancer\n* Hormone receptor positive breast cancer",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}